| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Scancell Holdings plc (OTCGREY: SCNLF)
SCNLF Technical Analysis
3
| As on 1st Jan 2026 SCNLF STOCK Price closed @ 0.14 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.01 & Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SCNLFSTOCK Price
| Open | 0.14 | Change | Price | % |
| High | 0.14 | 1 Day | 0.02 | 16.67 |
| Low | 0.14 | 1 Week | 0.00 | 0.00 |
| Close | 0.14 | 1 Month | -0.04 | -22.22 |
| Volume | 5000 | 1 Year | -0.04 | -22.22 |
| 52 Week High 0.18 | 52 Week Low 0.10 | ||||
OTCGREY USA Most Active Stocks
| XANAF | 0.04 | -33.33% |
| IARED | 24.62 | % |
| CVMCA | 22.54 | -0.75% |
| JRVMF | 0.01 | 0.00% |
| GCEA | 29.00 | -21.20% |
| TMCGF | 0.00 | % |
| AHLD | 82.75 | -2.93% |
| MAXC | 1.78 | 0.00% |
| KAKZF | 110.12 | 4.72% |
| CROOF | 0.06 | % |
OTCGREY USA Top Gainers Stocks
OTCGREY USA Top Losers Stocks
| SCNLF Daily Charts |
SCNLF Intraday Charts |
Whats New @ Bazaartrend |
SCNLF Free Analysis |
|
|
SCNLF Important Levels Intraday
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
SCNLF Forecast January 2026
| 4th UP Forecast | 0.39 |
| 3rd UP Forecast | 0.31 |
| 2nd UP Forecast | 0.26 |
| 1st UP Forecast | 0.21 |
| 1st DOWN Forecast | 0.07 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.11 |
SCNLF Weekly Forecast
| 4th UP Forecast | 0.24 |
| 3rd UP Forecast | 0.21 |
| 2nd UP Forecast | 0.19 |
| 1st UP Forecast | 0.17 |
| 1st DOWN Forecast | 0.11 |
| 2nd DOWN Forecast | 0.09 |
| 3rd DOWN Forecast | 0.07 |
| 4th DOWN Forecast | 0.04 |
SCNLF Forecast2026
| 4th UP Forecast | 0.39 |
| 3rd UP Forecast | 0.31 |
| 2nd UP Forecast | 0.26 |
| 1st UP Forecast | 0.21 |
| 1st DOWN Forecast | 0.07 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.11 |
Scancell Holdings plc ( OTCGREY USA Symbol : SCNLF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SCNLF Other Details
| Segment | EQ | |
| Market Capital | 222154800.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
SCNLF Address
![]() |
||
SCNLF Latest News
SCNLF Business Profile
Scancell Holdings plc engages in the discovery and development of novel vaccines for the treatment of various cancers. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 that is in phase I/II combination trials for the treatment of non-small cell lung cancer; and Modi-1, which is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2 that is in pre-clinical trial for the treatment of multiple solid tumors. The company has a research collaboration agreement with BioNTech to develop T-cell receptor based therapeutics; licensing and collaboration agreement with ISA Pharmaceuticals B.V. to use ISA's AMPLIVANT adjuvant technology for the development and commercialization of Modi-1; and collaboration agreements with Cobra Biologics, Centre for Research on Global Virus Infections, the University of Nottingham, and the Nottingham Trent University to develop a vaccine for COVID-19. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom. Address: John Eccles House, Oxford, United Kingdom, OX4 4GP
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

